Net shares · 365d
-21.3K
0 buy · 21.3K sell
Net value · 365d
-$1.7M
$0 in · $1.7M out
Sentiment · 365d
Net selling
0% buying · 100% selling
Open-market trades · 365d
1
0 buy · 21.3K sell
Trading track record · all companies
Not enough open-market trades to chart a track record yet.
Running net of open-market buys − sells across every company. Tap the line or a marker for details. ▲ buy · ▼ sell.
Transactions · 365d
-
MET Exercise·M
EVP & Chief Risk Officer
$0
21.3K sh · 2 lots
Own New
-
MET Sell·S
EVP & Chief Risk Officer
$1.7M
21.3K sh · $81.59
Own -12%
-
MET Exercise·M
EVP & Chief Risk Officer
$984.0K
21.3K sh · $46.17 avg · 2 lots
Own +14%
-
MET Other·F
EVP & Chief Risk Officer
$302.7K
4.1K sh · $73.24
Own -3%
-
MET Grant·A
EVP & Chief Risk Officer
—
30.0K sh · 2 lots
Own +22%
-
MET Other·F
EVP & Chief Risk Officer
$423.7K
5.6K sh · $75.34
Own -3%
-
RJF Exercise·M
Director
$0
1.3K sh
Own +2506%
-
RJF Grant·A
Director
$0
1.3K sh
Own +104%
-
RJF Exercise·M
Director
$0
1.3K sh
Own +17%
| Date▾ | Ticker | Type | Shares | Value |
|---|---|---|---|---|
| Jun 1, 2026 | MET | Exercise M | 21.3K2 lots | $0 |
| Jun 1, 2026 | MET | Sell S | 21.3K | $1.7M |
| Jun 1, 2026 | MET | Exercise M | 21.3K2 lots | $984.0K |
| Mar 2, 2026 | MET | Other F | 4.1K | $302.7K |
| Feb 24, 2026 | MET | Grant A | 30.0K2 lots | — |
| Feb 24, 2026 | MET | Other F | 5.6K | $423.7K |
| Feb 19, 2026 | RJF | Exercise M | 1.3K | $0 |
| Feb 19, 2026 | RJF | Grant A | 1.3K | $0 |
| Feb 19, 2026 | RJF | Exercise M | 1.3K | $0 |
Buy Sell Non-market (grant · exercise · gift)
About DEBEL MARLENE
This profile aggregates every SEC Form 4 insider transaction reported by DEBEL MARLENE across all companies they trade. Open-market purchases (code P) and sales (code S) are the highest-signal, discretionary trades; grants (A), option exercises (M) and gifts (G) reflect compensation rather than conviction and carry no market price. Figures cover the selected period and update as new filings are ingested.